ArticleInvestigational new drugs2025

Clinical potential of antibody-drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumors.

Ippei Miyamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.